IMC Chicago
FLNA

IMC Chicago’s Filana Therapeutics FLNA Stock Holding History

IMC Chicago’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.7K Buy
+24,100
New +$49.6K ﹤0.01% 5553
2024
Q4 		– Sell
-84,400
Closed -$2.48M – 3315
2024
Q3 		$2.48M Buy
+84,400
New +$1.94M ﹤0.01% 1537
2024
Q1 		– Sell
-14,600
Closed -$329K – 2481
2023
Q4 		$329K Buy
14,600
+300
+2% +$6.34K ﹤0.01% 1729
2023
Q3 		$238K Buy
+14,300
New +$283K ﹤0.01% 1564
2023
Q2 		– Sell
-36,500
Closed -$880K – 1382
2023
Q1 		$880K Sell
36,500
-93,600
-72% -$2.59M ﹤0.01% 1075
2022
Q4 		$3.84M Sell
130,100
-196,300
-60% -$7.06M 0.01% 677
2022
Q3 		$13.7M Buy
326,400
+305,900
+1,492% +$8.26M 0.02% 377
2022
Q2 		$576K Sell
20,500
-89,600
-81% -$2.26M ﹤0.01% 946
2022
Q1 		$4.09M Sell
110,100
-140,500
-56% -$5.95M ﹤0.01% 599
2021
Q4 		$11M Buy
250,600
+11,400
+5% +$598K 0.01% 471
2021
Q3 		$14.8M Buy
239,200
+212,500
+796% +$17.7M 0.02% 421
2021
Q2 		$2.28M Buy
+26,700
New +$1.43M ﹤0.01% 745

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

IMC Chicago's FLNA Position: Q4 2024 in Review

IMC Chicago sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 39,792 shares — an estimated $699K sold.

IMC Chicago first reported a position in FLNA in Q2 2021 and held it in 6 quarters. The position peaked at $1.84M in Q4 2022. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • IMC Chicago reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • IMC Chicago sold 39,792 Filana Therapeutics shares in Q4 2024, an estimated $699K.
  • IMC Chicago first reported a position in Filana Therapeutics in Q2 2021 and held it in 6 quarters.
  • IMC Chicago's Filana Therapeutics position peaked at $1.84M in Q4 2022.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on IMC Chicago's 13F filing for Q4 2024, filed 27 Jan 2025.